234 related articles for article (PubMed ID: 7529598)
1. The insulin-like growth factor system as a target in breast cancer.
Yee D
Breast Cancer Res Treat; 1994; 32(1):85-95. PubMed ID: 7529598
[TBL] [Abstract][Full Text] [Related]
2. Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action.
McGuire WL; Jackson JG; Figueroa JA; Shimasaki S; Powell DR; Yee D
J Natl Cancer Inst; 1992 Sep; 84(17):1336-41. PubMed ID: 1379645
[TBL] [Abstract][Full Text] [Related]
3. Potential therapeutic strategies to interrupt insulin-like growth factor signaling in breast cancer.
Byron SA; Yee D
Semin Oncol; 2003 Oct; 30(5 Suppl 16):125-32. PubMed ID: 14613033
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line.
Chen JC; Shao ZM; Sheikh MS; Hussain A; LeRoith D; Roberts CT; Fontana JA
J Cell Physiol; 1994 Jan; 158(1):69-78. PubMed ID: 7505280
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone and the insulin-like growth factor system in myogenesis.
Florini JR; Ewton DZ; Coolican SA
Endocr Rev; 1996 Oct; 17(5):481-517. PubMed ID: 8897022
[TBL] [Abstract][Full Text] [Related]
6. Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I, serum, and estrogen-dependent growth of MCF-7 human breast cancer cells.
Figueroa JA; Sharma J; Jackson JG; McDermott MJ; Hilsenbeck SG; Yee D
J Cell Physiol; 1993 Nov; 157(2):229-36. PubMed ID: 7693722
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor.
Arteaga CL; Osborne CK
Cancer Res; 1989 Nov; 49(22):6237-41. PubMed ID: 2553250
[TBL] [Abstract][Full Text] [Related]
8. Regulation of insulin-like growth factor (IGF) binding protein-5 in the T47D human breast carcinoma cell line by IGF-I and retinoic acid.
Shemer J; Yaron A; Werner H; Shao ZM; Sheikh MS; Fontana JA; LeRoith D; Roberts CT
J Clin Endocrinol Metab; 1993 Nov; 77(5):1246-50. PubMed ID: 7521344
[TBL] [Abstract][Full Text] [Related]
9. Secretion and biological actions of insulin-like growth factor binding proteins in two human tumor-derived cell lines in vitro.
Camacho-Hubner C; McCusker RH; Clemmons DR
J Cell Physiol; 1991 Aug; 148(2):281-9. PubMed ID: 1715344
[TBL] [Abstract][Full Text] [Related]
10. The insulin-like growth factor binding proteins (IGFBPs) in human breast cancer.
Figueroa JA; Yee D
Breast Cancer Res Treat; 1992; 22(1):81-90. PubMed ID: 1384805
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor binding protein 1 expression inhibits insulin-like growth factor I action in MCF-7 breast cancer cells.
Yee D; Jackson JG; Kozelsky TW; Figueroa JA
Cell Growth Differ; 1994 Jan; 5(1):73-7. PubMed ID: 7510125
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol.
Martin JL; Coverley JA; Pattison ST; Baxter RC
Endocrinology; 1995 Mar; 136(3):1219-26. PubMed ID: 7532580
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factors (IGFs): implications for aging.
Cohen P; Ocrant I; Fielder PJ; Neely EK; Gargosky SE; Deal CI; Ceda GP; Youngman O; Pham H; Lamson G
Psychoneuroendocrinology; 1992 Aug; 17(4):335-42. PubMed ID: 1279737
[TBL] [Abstract][Full Text] [Related]
14. The insulin-like growth factor system as a treatment target in breast cancer.
Yee D
Semin Oncol; 2002 Jun; 29(3 Suppl 11):86-95. PubMed ID: 12138402
[TBL] [Abstract][Full Text] [Related]
15. Insulinlike growth factors and binding proteins in colon cancer.
Singh P; Rubin N
Gastroenterology; 1993 Oct; 105(4):1218-37. PubMed ID: 7691674
[TBL] [Abstract][Full Text] [Related]
16. Regulation of insulin-like growth factor (IGF) bioactivity by sequential proteolytic cleavage of IGF binding protein-4 and -5.
Laursen LS; Kjaer-Sorensen K; Andersen MH; Oxvig C
Mol Endocrinol; 2007 May; 21(5):1246-57. PubMed ID: 17312271
[TBL] [Abstract][Full Text] [Related]
17. Regulation of DU145 human prostate cancer cell proliferation by insulin-like growth factors and its interaction with the epidermal growth factor autocrine loop.
Connolly JM; Rose DP
Prostate; 1994 Apr; 24(4):167-75. PubMed ID: 7511802
[TBL] [Abstract][Full Text] [Related]
18. Cellular actions of the insulin-like growth factor binding proteins.
Firth SM; Baxter RC
Endocr Rev; 2002 Dec; 23(6):824-54. PubMed ID: 12466191
[TBL] [Abstract][Full Text] [Related]
19. Physiologic and clinical relevance of the insulin-like growth factor binding proteins.
Cohen P; Rosenfeld RG
Curr Opin Pediatr; 1994 Aug; 6(4):462-7. PubMed ID: 7951670
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of insulin-like growth factor (IGF)-binding proteins-1 and -3 on IGF-activated glucose consumption in mouse BALB/c 3T3 fibroblasts.
Okajima T; Iwashita M; Takeda Y; Sakamoto S; Tanabe T; Yasuda T; Rosenfeld RG
J Endocrinol; 1993 Mar; 136(3):457-70. PubMed ID: 7682592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
